{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:23:54Z","timestamp":1789424634763,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,11]],"date-time":"2014-05-11T00:00:00Z","timestamp":1399766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11064-014-1322-2","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T15:54:47Z","timestamp":1399737287000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral Tests"],"prefix":"10.1007","volume":"39","author":[{"given":"Yeshwant","family":"Kurhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,11]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","volume":"11","author":"AD Lopez","year":"1998","unstructured":"Lopez AD, Murray CC (1998) The global burden of disease, 1990\u20132020. Nat Med 11:1241\u20131243","journal-title":"Nat Med"},{"key":"1322_CR2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","volume":"63","author":"GE Simon","year":"2006","unstructured":"Simon GE, Von-Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, Kessler RC (2006) Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63:824\u2013830","journal-title":"Arch Gen Psychiatry"},{"key":"1322_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.08m04743blu","volume":"71","author":"N Vogelzangs","year":"2010","unstructured":"Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Penninx BW (2010) Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 71:391\u2013399","journal-title":"J Clin Psychiatry"},{"key":"1322_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsycho-pharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137\u2013162","journal-title":"Neuropsychopharmacology"},{"key":"1322_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2310\/6650.2007.06031","volume":"55","author":"RG McMurray","year":"2007","unstructured":"McMurray RG, Zaldivar F, Galassetti P, Larson J, Eliakim A, Nemet D, Cooper DM (2007) Cellular immunity and inflammatory mediator responses to intense exercise in overweight children and adolescents. J Investig Med 55:120\u2013129","journal-title":"J Investig Med"},{"key":"1322_CR6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"1322_CR7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","volume":"31","author":"YK Kim","year":"2007","unstructured":"Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB (2007) Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1044\u20131053","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1322_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(96)01295-4","volume":"749","author":"R Yirmiya","year":"1997","unstructured":"Yirmiya R, Barak O, Avitsur R, Avitsur R, Gallily R, Weidenfeld J (1997) Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins. Brain Res 749:71\u201381","journal-title":"Brain Res"},{"key":"1322_CR9","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-\u03b1 in human obesity and insulin resistance. J Clin Invest 95:2409\u20132415","journal-title":"J Clin Invest"},{"key":"1322_CR10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal KT, Wiesbrock SM, Marino MV, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-\u03b1 function. Nature 389:610\u2013614","journal-title":"Nature"},{"key":"1322_CR11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2174\/138161208784480243","volume":"14","author":"N Muller","year":"2008","unstructured":"Muller N, Schwarz MJ (2008) COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des 14:1452\u20131465","journal-title":"Curr Pharm Des"},{"key":"1322_CR12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/oby.2008.674","volume":"17","author":"PS Hsieh","year":"2009","unstructured":"Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC (2009) COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity 17:1150\u20131157","journal-title":"Obesity"},{"key":"1322_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313\u2013320","journal-title":"Pharmacol Res"},{"key":"1322_CR14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euroneuro.2007.03.001","volume":"17","author":"PC Casarotto","year":"2007","unstructured":"Casarotto PC, Andreatini R (2007) Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur Neuropsychopharmacol 17:735\u2013742","journal-title":"Eur Neuropsychopharmacol"},{"key":"1322_CR15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/jpet.102.045716","volume":"306","author":"M Filip","year":"2003","unstructured":"Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306:734\u2013743","journal-title":"J Pharmacol Exp Ther"},{"key":"1322_CR16","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1322_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66\u201372","journal-title":"Psychopharmacology"},{"key":"1322_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"1322_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jphs.08201SC","volume":"108","author":"J Kamei","year":"2008","unstructured":"Kamei J, Miyata S, Sunohara T, Kamei A, Shimada M, Ohsawa M (2008) Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test. J Pharmacol Sci 108:381\u2013384","journal-title":"J Pharmacol Sci"},{"key":"1322_CR20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","volume":"24","author":"S Pellow","year":"1986","unstructured":"Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525\u2013529","journal-title":"Pharmacol Biochem Behav"},{"key":"1322_CR21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jep.2005.11.035","volume":"106","author":"OO Adeyemi","year":"2006","unstructured":"Adeyemi OO, Yemitan OK, Taiwo AE (2006) Neurosedative and muscle-relaxant activities of ethyl acetate extract of Baphia nitidia AFZEL. J Ethnopharmacol 106:312\u2013316","journal-title":"J Ethnopharmacol"},{"key":"1322_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/000456326900600108","volume":"6","author":"P Trinder","year":"1969","unstructured":"Trinder P (1969) Enzymatic method of glucose estimation. Ann Clin Biochem 6:24\u201333","journal-title":"Ann Clin Biochem"},{"key":"1322_CR23","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/clinchem\/24.12.2161","volume":"24","author":"F Meittini","year":"1978","unstructured":"Meittini F, Prencipe F, Bardelli G, Giannini G, Tarli P (1978) The 4-hydroxybenzoate\/4-aminophenazone chromogenic system. Clin Chem 24:2161\u20132165","journal-title":"Clin Chem"},{"key":"1322_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/19.5.476","volume":"19","author":"G Buccolo","year":"1973","unstructured":"Buccolo G, David H (1973) Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19:476\u2013482","journal-title":"Clin Chem"},{"key":"1322_CR25","first-page":"1316","volume-title":"Clinical chemistry, theory, analysis, and correlation","author":"A Koller","year":"1984","unstructured":"Koller A (1984) Total serum protein. In: Kaplan LA, Pesce AJ (eds) Clinical chemistry, theory, analysis, and correlation. Mosby Company, St. Louis, pp 1316\u20131319"},{"key":"1322_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/qjmed\/hcl085","volume":"99","author":"SDH Malnick","year":"2006","unstructured":"Malnick SDH, Knobler H (2006) The medical complications of obesity. Q J Med 99:565\u2013579","journal-title":"Q J Med"},{"key":"1322_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ijo.2008.268","volume":"33","author":"G Zhao","year":"2009","unstructured":"Zhao G, Ford ES, Dhingra S, Li C, Strine TW, Mokdad AH (2009) Depression and anxiety among US adults: associations with body mass index. Int J Obes (Lond) 33:257\u2013266","journal-title":"Int J Obes (Lond)"},{"key":"1322_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ijo.2012.48","volume":"37","author":"S Sharma","year":"2012","unstructured":"Sharma S, Fulton S (2012) Diet-induced obesity promotes depressive-like behavior that is associated with neural adaptations in brain reward circuitry. Int J Obes 37:382\u2013389","journal-title":"Int J Obes"},{"key":"1322_CR29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.08m04743blu","volume":"71","author":"N Vogelzangs","year":"2010","unstructured":"Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Penninx BW (2010) Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 71:391\u2013399","journal-title":"J Clin Psychiatry"},{"key":"1322_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.31887\/DCNS.2011.13.1\/rshelton","volume":"13","author":"RC Shelton","year":"2011","unstructured":"Shelton RC, Miller AH (2011) Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci 13:41\u201353","journal-title":"Dialogues Clin Neurosci"},{"key":"1322_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","volume":"29","author":"R Dantzer","year":"2009","unstructured":"Dantzer R (2009) Cytokine, sickness behavior and depression. Immunol Allergy Clin North Am 29:247\u2013264","journal-title":"Immunol Allergy Clin North Am"},{"key":"1322_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000107420","volume":"14","author":"AM Myint","year":"2007","unstructured":"Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE (2007) Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. NeuroImmunoModulation 14:65\u201371","journal-title":"NeuroImmunoModulation"},{"key":"1322_CR33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.03.076","volume":"612","author":"JY Guo","year":"2009","unstructured":"Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F (2009) Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 612:54\u201360","journal-title":"Eur J Pharmacol"},{"key":"1322_CR34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/JGP.0b013e3181b047e3","volume":"17","author":"OP Almeida","year":"2009","unstructured":"Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L (2009) Obesity and metabolic syndrome increases the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 17:889\u2013898","journal-title":"Am J Geriatr Psychiatry"},{"key":"1322_CR35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","volume":"35","author":"A Der-Avakian","year":"2012","unstructured":"Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68\u201377","journal-title":"Trends Neurosci"},{"key":"1322_CR36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"1322_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","volume":"54","author":"S Hogg","year":"1996","unstructured":"Hogg S (1996) A review of the validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"1322_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0149-7634(98)00027-X","volume":"23","author":"SM Weiss","year":"1998","unstructured":"Weiss SM, Wadsworth G, Fletcher A, Dourish CT (1998) Utility of ethological analysis to overcome locomotor confounds in elevated plus-maze of anxiety. Neurosci Biobehav Rev 23:265\u2013271","journal-title":"Neurosci Biobehav Rev"},{"key":"1322_CR39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2007.11.002","volume":"109","author":"A Pan","year":"2006","unstructured":"Pan A, Ye X, Franco OH, Li H, Yu Z, Zou S, Lin X (2006) Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord 109:75\u201382","journal-title":"J Affect Disord"},{"key":"1322_CR40","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.2337\/diacare.27.12.2856","volume":"27","author":"SA Everson-Rose","year":"2004","unstructured":"Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, Matthews KA (2004) Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27:2856\u20132862","journal-title":"Diabetes Care"},{"key":"1322_CR41","first-page":"643","volume":"232","author":"S Lu","year":"2007","unstructured":"Lu S, Archer MC (2007) Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1. Exp Biol Med 232:643\u2013653","journal-title":"Exp Biol Med"},{"key":"1322_CR42","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI118717","volume":"97","author":"GD Anderson","year":"1996","unstructured":"Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA (1996) Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672\u20132679","journal-title":"J Clin Invest"},{"key":"1322_CR43","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/en.2011-0004","volume":"152","author":"N Yamada","year":"2011","unstructured":"Yamada N, Katsuura G, Ochi Y, Ebihara K, Kusakabe T, Hosoda K, Nakao K (2011) Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152:2634\u20132643","journal-title":"Endocrinology"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-014-1322-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-014-1322-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-014-1322-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:53:59Z","timestamp":1648986839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-014-1322-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,11]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s11064-014-1322-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,11]]}}}